Form F-1/A NeuroSense Therapeutics
Tweet
Share
E-mail
http://archive.fast-edgar.com/20211206/AV22D22CLZ22OJ4222TD2ZY27HDGM222Y232
Filed on: December 6, 2021
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tiziana Life Sciences (TLSA) Reports Positive 3-Month Neuroimaging Scores in Multiple Sclerosis Patients Receiving Intranasal Foralumab
- YY Group Holding (YYGH) Closes $5M IPO
- YS Biopharma (YS) Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
F1Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
